Completed NA INTERVENTIONAL NCT00461435
Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa
Sponsor: Azienda Policlinico Umberto I
Conditions
Retinitis Pigmentosa
Interventions
hyperbaric oxygen therapy
Updated 4 times since 2017 Last updated: Apr 17, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00461435, this NA trial focuses on Retinitis Pigmentosa and remains completed. Sponsored by Azienda Policlinico Umberto I, it has been updated 4 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2017 — Jan 2021 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Azienda Policlinico Umberto I
Data source: Azienda Policlinico Umberto I
For direct contact, visit the study record on ClinicalTrials.gov .